207_Combined course Presentations

First page Table of contents Previous page 1248 Next page Last page

TROG 12.01 phase III CRT vs RT+Cetuximab

Exclusion

Intermediate-risk subset of p16+ OPC: Heavy smoking (>10packyears) Bulky nodal disease (>N2b)

Made with